earnings

Roche sees a slight dip in Q1 as biosim­i­lars keep bit­ing in­to block­buster on­col­o­gy tri­o's sales
Endpoints
Wed, 04/21/21 - 10:40 am
Roche
earnings
biosimilars
Abbott Profits Triple As Over-the-counter Covid-19 Tests Hit Drugstore Shelves
Forbes
Tue, 04/20/21 - 11:11 am
Abbott Labs
COVID-19
earnings
diagnostics
How Johnson & Johnson Beat Expectations in Q1
Motley Fool
Tue, 04/20/21 - 11:09 am
JNJ
earnings
COVID-19
vaccines
6 medtechs to watch when earnings kick off next week
Medtech Dive
Fri, 04/16/21 - 09:49 am
earnings
devices
Abbott Labs
Edwards Lifesciences
Intuitive Surgical
JNJ
Roche
Quest Diagnostics
BioNTech's Q4 Results Wowed but Were Just the Tip of the Iceberg
Motley Fool
Tue, 03/30/21 - 11:58 am
BioNTech
earnings
vaccines
COVID-19
Pfizer
These 2 Elements in Novavax's Earnings Report Could Mean Billions for the Biotech
Motley Fool
Thu, 03/4/21 - 11:33 pm
Novavax
earnings
Medtech’s haves and have-nots
EP Vantage
Wed, 02/24/21 - 10:59 am
earnings
devices
Medtech
Medtronic
EXACT Sciences
Thermo Fisher
Abbott Labs
Roche
Qiagen
JNJ
Zimmer Biomet
Smith & Nephew
Boston Scientific
Medtronic Gains Momentum in Diabetes
Medical Devices and Diagnostics Industry
Tue, 02/23/21 - 11:03 pm
Medtronic
earnings
devices
diabetes
Here's What I'll Be Looking for in Moderna's Earnings Report Next Week
Motley Fool
Sat, 02/20/21 - 11:32 pm
Moderna Therapeutics
earnings
Pharma’s pipeline continues to provide drama as investors look beyond COVID in Q4
Pharmaforum
Fri, 02/19/21 - 10:33 am
pharma industry
R&D
pandemic
earnings
COVID-19
Biogen
GW Pharma
Jazz Pharmaceuticals
GSK
Merck KGaA
GW Pharmaceuticals Beats on Revenue, Bottom Line for Q4
Motley Fool
Tue, 02/16/21 - 11:39 pm
GW Pharma
earnings
Exact Sciences Falls in After-Hours Trading on Q4 Results
Motley Fool
Tue, 02/16/21 - 11:39 pm
EXACT Sciences
earnings
The Week Ahead In Biotech: FDA Decision On G1 Therapeutics, Earnings In The Mix For Light Calendar Week
Yahoo/Benzinga
Mon, 02/15/21 - 10:37 am
earnings
FDA
G1 Therapeutics
trilaciclib
Zoetis
EXACT Sciences
Blueprint Medicines
Ironwood Pharmaceuticals
3 Q4 takeaways: COVID-19 testing strong (for now), electives hit, and M&A
Medtech Dive
Fri, 02/12/21 - 10:50 am
devices
earnings
COVID-19
pandemic
Why Alkermes' Q4 Results Were Better Than They Might Seem
Motley Fool
Thu, 02/11/21 - 10:25 pm
Alkermes
earnings
How Pacific Biosciences Beat Expectations in Q4
Motley Fool
Thu, 02/11/21 - 10:30 am
Pacific Biosciences
earnings
What's Behind Incyte's Better-Than-Expected Q4 Earnings
Motley Fool
Tue, 02/9/21 - 11:57 pm
Incyte
earnings
Sanofi flunks Parkinson's Phase II, axes handful of mid-stage programs in Q4 earnings
Endpoints
Fri, 02/5/21 - 10:55 am
Sanofi
earnings
Parkinson's Disease
drug development
Veklury rescues Gilead from COVID doldrums in Q4
Pharmaforum
Fri, 02/5/21 - 10:44 am
Gilead Sciences
Veklury
earnings
Coronavirus uncertainty clouds Quest's 2d half amid Q4 revenue bump
Medtech Dive
Fri, 02/5/21 - 10:43 am
Quest Diagnostics
diagnostics
earnings
COVID-19

Pages